COV files SEC Form-10 for planned 2Q13 spinoff of Mallinckrodt, COV’s pharma division (which used to be part of Tyco): http://www.sec.gov/Archives/edgar/data/1385187/000138518713000006/cov-2013020113xex991.htm Seems like everyone is doing spinoffs these days.